Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/VYVGART

Authorized

STANDARD

VYVGART

ARGENX BV🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 9b5060ebb402b9c2
Company: ARGENX BV
Type: Standard

Approval Details

Approval Id: 9b5060ebb402b9c2
Drug Approval Canada Name: VYVGART
Product Name: VYVGART
Status: Marketed
Status Date: 2023-11-06
Original Market Date: 2023-11-06
Din: 02541599
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 90:28.00
Atc Original: L04AA58 EFGARTIGIMOD ALFA
Atc Name: l 04 aa 58
Aig Number: 0165001001
Company Name: ARGENX BV
Company Address: Industriepark Zwijnaarde 7, Zwijnaarde, --, Belgium, 9052
Company Detail Path: /organization/argenx-bv

Company Information

Pharmaceutical Company Name: ARGENX BV
Country Name: Sweden
Address: Utländsk Adr - Foreign Addr

Active Ingredients

EFGARTIGIMOD ALFA

20 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9b5060ebb402b9c2

Type

Standard

Back to Health Canada Approvals

VYVGART - Health Canada Drug Approval Details